BTIG raised the firm’s price target on Boston Scientific (BSX) to $132 from $127 and keeps a Buy rating on the shares. The firm notes the company’s biennial investor day Tuesday in NYC, during which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback